Monogram Orthopaedics Inc. (MGRM) Financials

$6.00

$0.00 (0.00%)

As on 08-Oct-2025 09:30EDT

Market cap

$244 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

28

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.43	--	0.37	--	0.63	0.63
Cost of Revenue	0.58	0.43	0.41	0.39	0.46	0.10
Gross Profit	-0.15	-0.43	0.37	-0.39	0.17	-0.10
Operating Expenses	14.32	14.88	17.63	10.36	10.45	6.85
Operating Profit (EBIT)	-14.47	-15.31	-17.27	-10.61	-10.28	-6.85
Other Income	--	--	--	--	--	--
Profit before Tax	-17.91	-16.33	-13.75	-13.69	-11.81	-9.07
Provision for Tax	0.00	--	0.00	3.33	0.02	0.05
Profit after Tax (Net Income)	-17.91	-16.33	-13.75	-13.69	-11.81	-9.07
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-13.69	-11.81	-9.07

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	8.62	14.50	13.40	4.15	3.50	4.99
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.15	1.73	0.36	0.49	0.12	0.15
Current Liabilities	6.23	1.54	2.82	9.05	5.09	2.98
Total Liabilities	21.23	17.77	16.58	13.69	8.72	8.12

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	1.54	1.49	1.96	2.43	2.21	1.69
Current Assets	13.46	16.28	14.62	11.26	6.50	6.43
Total Assets	21.23	17.77	16.58	13.69	8.72	8.12
Total Debt*	0.30	0.36	0.49	0.61	0.21	0.21
Net Current Assets	7.23	14.74	11.80	2.21	1.41	3.45

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-13.97	-13.54	-8.42	-9.17	-5.40
Cash Flow from Investing Activities	--	-0.08	-0.06	-0.24	-1.01	-1.33
Cash from Financing Activities	--	16.12	16.73	13.59	10.12	10.01
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.53	-0.50	-0.44	-1.42	-1.22	-0.96
Cash EPS ($)	--	-0.49	-0.43	-1.38	-1.19	-0.95
Adjusted Book Value ($)	--	0.45	0.43	0.43	0.36	0.53
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.43	-0.43	-0.87	-0.95	-0.57
Free Cash Flow per Share ($)	--	-0.43	-0.43	-0.90	-1.05	-0.72

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-113.56	-147.41	-323.13	-265.22	-257.46
ROE (%)	-154.96	-117.05	-156.67	-357.82	-278.24	-384.66
ROA (%)	-106.88	-95.07	-90.82	-122.21	-140.39	-168.93
EBIT Margin (%)	-3,436.13	--	-4,730.97	--	-1,635.93	-1,090.45
Net Margin (%)	-4,210.19	--	-3,765.81	--	-1,880.63	-1,443.38
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	16.57	-1.00	--	-1.00	--	--
EBIT Growth (%)	1.73	5.44	-62.70	-3.26	-50.02	-309.78
Net Profit Growth (%)	-53.19	-18.79	-0.40	-15.88	-30.29	-404.83
EPS Growth (%)	-41.89	-0.14	0.69	-0.16	-0.27	-3.61
Book Value Growth (%)	8.75	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-4.73	-7.84	--	--	--
Price / Book Value	27.98	5.32	8.05	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.10	-3.89	-5.62	--	--	--
Close Price ($)	2.89	2.37	3.44	--	--	--
High Price ($)	4.21	4.90	48.99	--	--	--
Low Price ($)	1.92	1.53	2.46	--	--	--
Market Cap ($ Cr)	243.79	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.03	0.04	0.15	0.06	0.04
Short term debt to equity ratio	0.02	0.02	0.01	0.03	0.03	0.01
Current Ratio	2.16	10.57	5.19	1.24	1.28	2.16
Quick Ratio	2.11	10.38	5.19	1.24	1.17	--
Interest Coverage	--	--	--	--	-474.48	-126.28

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	22.80	--	100.00	--	66.61	--
Asset Turnover	0.03	--	0.02	--	0.07	0.12
Receivable days	--	--	261.48	--	243.31	--
Inventory Days	--	122.32	2.02	266.35	445.46	--
Payable days	--	1,544.36	1,384.27	525.27	251.57	826.70
Cash Conversion Cycle	--	--	-1,120.78	--	437.20	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.